Medicines in Development for Alzheimer's Disease 2017 Report

PhRMA September 20, 2017

America’s biopharmaceutical research companies are investigating or developing 85 medicines to help the more than five million patients in the United States who are living with Alzheimer’s.

Get your free copy of the report now.

* Required fields
By submitting your email, you will be subscribed to regular updates from PhRMA.